DexCom
DXCM
DXCM
273 hedge funds and large institutions have $5.96B invested in DexCom in 2017 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 73 increasing their positions, 112 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 275 → 273 (-2)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 112
Holders
273
Holding in Top 10
2
Calls
$31.8M
Puts
$15.4M
Top Buyers
| 1 | +$315M | |
| 2 | +$195M | |
| 3 | +$80.7M | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$53.1M |
| 5 |
BM
Bridger Management
New York
|
+$48.8M |
Top Sellers
| 1 | -$248M | |
| 2 | -$94.5M | |
| 3 | -$64.4M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$52.7M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$29.4M |